Jinhua Li Selected Research

Colonic Neoplasms (Colon Cancer)

8/2022	LncRNA-CCAT1/miR-152-3p is involved in CSE-induced inflammation in HBE cells via regulating ERK signaling pathway.
1/2009	Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinhua Li Research Topics

Disease

53	Neoplasms (Cancer) 01/2024 - 10/2002
18	Inflammation (Inflammations) 04/2024 - 11/2006
13	Fibrosis (Cirrhosis) 04/2024 - 11/2006
8	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 02/2009
6	Infections 10/2023 - 09/2013
6	Chronic Obstructive Pulmonary Disease (COPD) 08/2022 - 01/2017
5	Ischemic Stroke 01/2024 - 09/2022
5	Breast Neoplasms (Breast Cancer) 08/2022 - 09/2006
4	COVID-19 12/2022 - 01/2020
4	Neoplasm Metastasis (Metastasis) 08/2022 - 10/2010
4	Carcinoma (Carcinomatosis) 10/2019 - 01/2009
4	Melanoma (Melanoma, Malignant) 03/2006 - 10/2002
3	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 09/2022
3	Neuroinflammatory Diseases 03/2024 - 01/2023
3	Brain Ischemia (Cerebral Ischemia) 12/2023 - 01/2018
3	Carcinogenesis 08/2023 - 03/2015
3	Hypertension (High Blood Pressure) 01/2021 - 01/2019
3	Bacterial Infections (Bacterial Infection) 08/2017 - 01/2016
3	Proteinuria 01/2016 - 01/2013
3	Hypoxia (Hypoxemia) 10/2014 - 05/2006
3	Nephrosis 03/2007 - 10/2006
2	Thrombosis (Thrombus) 02/2024 - 01/2022
2	Cerebral Infarction 01/2024 - 12/2023
2	Reperfusion Injury 12/2023 - 11/2008
2	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 01/2023
2	Myocardial Infarction 09/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 08/2022 - 01/2009
2	Body Weight (Weight, Body) 05/2022 - 01/2017
2	Polyploidy 03/2022 - 01/2021
2	Osteoporosis 01/2022 - 10/2020
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2021 - 08/2021
2	Lymphopenia (Lymphocytopenia) 01/2020 - 09/2004
2	Cholangiocarcinoma 03/2019 - 12/2014
2	Emphysema 01/2017 - 01/2017
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2002
7	Peptides (Polypeptides)IBA 04/2024 - 03/2004
7	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2016 - 10/2006
5	LipidsIBA 11/2022 - 12/2012
5	SmokeIBA 08/2022 - 01/2017
5	TitaniumIBA 01/2022 - 01/2012
5	Biocompatible Materials (Biomaterials)IBA 03/2021 - 01/2016
4	discoidin-binding polysaccharideIBA 12/2023 - 05/2014
4	AlkaloidsIBA 10/2023 - 01/2021
4	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 01/2019
4	CytokinesIBA 11/2019 - 10/2002
4	Interleukin-2 (IL2)IBA 09/2007 - 10/2002
3	AntioxidantsIBA 04/2024 - 01/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 10/2014
3	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2024 - 11/2022
3	Therapeutic UsesIBA 02/2024 - 12/2021
3	ApigeninIBA 01/2024 - 11/2022
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2020
3	SolutionsIBA 11/2023 - 12/2021
3	GraphiteIBA 11/2023 - 09/2015
3	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2012
3	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2020
3	ElementsIBA 10/2023 - 11/2012
3	2,6-dichlorobenzoquinoneIBA 01/2023 - 03/2013
3	CateninsIBA 08/2022 - 10/2019
3	Drinking WaterIBA 01/2018 - 10/2014
3	LigandsIBA 09/2016 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2014 - 02/2009
3	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2014 - 11/2006
3	VaccinesIBA 01/2009 - 03/2006
3	p38 Mitogen-Activated Protein KinasesIBA 03/2007 - 10/2006
2	InflammasomesIBA 04/2024 - 01/2018
2	andrographolideIBA 03/2024 - 12/2023
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 01/2020
2	Neuroprotective AgentsIBA 12/2023 - 11/2022
2	ResveratrolIBA 10/2023 - 09/2010
2	Antimitotic AgentsIBA 08/2023 - 07/2022
2	Aurora Kinase BIBA 08/2023 - 03/2022
2	isoquinolineIBA 06/2023 - 08/2022
2	Blood Glucose (Blood Sugar)IBA 11/2022 - 01/2021
2	AcidsIBA 09/2022 - 12/2014
2	StrontiumIBA 01/2022 - 06/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2019
2	Transient Receptor Potential ChannelsIBA 11/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2005
2	AntigensIBA 01/2021 - 05/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 10/2014
2	fibrin fragment D (D-dimer)IBA 01/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2017
2	Lipid NanoparticlesIBA 01/2020 - 01/2019
2	EnzymesIBA 08/2018 - 02/2009
2	Conditioned Culture MediaIBA 01/2017 - 01/2016
2	ethyl acetateIBA 01/2017 - 01/2013

Therapy/Procedure

26	Therapeutics 01/2024 - 03/2004
8	Immunotherapy 03/2021 - 10/2002
7	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
3	Transplantation 08/2021 - 02/2017
3	Optical Fibers 10/2011 - 07/2010
2	Lasers (Laser) 01/2024 - 04/2018
2	Laser Therapy (Surgery, Laser) 01/2024 - 12/2021
2	Percutaneous Coronary Intervention 09/2022 - 01/2021
2	Radiotherapy 01/2022 - 01/2021
2	Electrodes (Electrode) 01/2020 - 11/2011
2	Intraperitoneal Injections 01/2017 - 12/2008